Literature DB >> 8157070

Mechanism of delta-opioid receptor selection by the address domain of dermenkephalin.

S Charpentier1, S Sagan, M Naim, A Delfour, P Nicolas.   

Abstract

Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-AspNH2) is a highly potent and selective delta-opioid peptide isolated from frog skin. It was recently recognized that the C-terminus His4-Leu5-Met6-Asp7NH2 of dermenkephalin was responsible for the addressing of the peptide towards the delta-opioid receptor. In order to investigate the role played by residues 4, 5 and 6 in this 'delta address', we synthesized and evaluated 20 new analogues for their ability to displace tritiated ligands from mu- and delta-opioid sites. Results showed that position 4 of dermenkephalin contributes to delta selectivity independently of delta-opioid receptor binding by preventing a high affinity mu binding. Position 5 requires a hydrophobic side chain to enhance delta affinity. A high delta affinity was obtained with any amino acids introduced in position 6 suggesting that residue 6 serves as a neutral spacer. Thus, the main features responsible for the high delta-opioid selectivity of dermenkephalin are electrostatic repulsions with the mu-opioid receptor, additional hydrophobic interactions with the delta-opioid receptor and folding of the C-terminal domain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157070     DOI: 10.1016/0922-4106(94)90107-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Synthesis and pharmacology of halogenated δ-opioid-selective [d-Ala(2)]deltorphin II peptide analogues.

Authors:  Robyn Pescatore; Gina F Marrone; Seth Sedberry; Daniel Vinton; Netanel Finkelstein; Yitzchak E Katlowitz; Gavril W Pasternak; Krista R Wilson; Susruta Majumdar
Journal:  ACS Chem Neurosci       Date:  2015-04-14       Impact factor: 4.418

Review 2.  Frog skin opioid peptides: a case for environmental mimicry.

Authors:  L H Lazarus; S D Bryant; M Attila; S Salvadori
Journal:  Environ Health Perspect       Date:  1994-08       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.